Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: A systematic review and meta-analysis

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Lin, Kuan Ho ^a,b   Chang, Shy Shin ^c,d   Yu, Chin Wei ^c,d   Lin, Shen Che ^c,d   Liu, Shu Chun ^c,d   Chao, Hsiao Yun ^c,d   Lee, Meng Tse Gabriel ^e   Wu, Jiunn Yih ^c,d   Lee, Chien Chang ^e,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR; BIOLOGICAL MARKER;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEVER; HUMAN; META ANALYSIS; METHODOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ACUTE DISEASE; BLOOD; PROSPECTIVE STUDY;

ACUTE DISEASE; BIOMARKERS; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84929334826     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006703     Document Type: Article

References (29)

1. Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991;118:680-6.
2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71.
3. Kishimoto S, Suda K, Teramachi Y, et al. Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease. Pediatr Int 2011;53:736-41.
4. Sonobe T, Kiyosawa N, Tsuchiya K, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007;49:421-6.
5. Nakao K, Ogawa Y, Suga S, et al. Molecular biology and biochemistry of the natriuretic peptide system. II: natriuretic peptide receptors. J Hypertens 1992;10:1111-14.
6. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
7. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7.
8. Yutani C, Go S, Kamiya T, et al. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med 1981;105:470-3.
9. Yonesaka S, Takahashi T, Matubara T, et al. Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. Jpn Circ J 1992;56:352-8.
10. McNeal-Davidson A, Fournier A, Spigelblatt L, et al. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease. Pediatr Int 2012;54:627-33.
11. Bang S, Yu JJ, Han MK, et al. Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction. Korean J Pediatr 2011;54:340-4.
12. Cho SY, Kim Y, Cha SH, et al. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP? Ann Clin Lab Sci 2011;41:360-3.
13. Dahdah N, Siles A, Fournier A, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009;30:810-17.
14. Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000;42:241-8.
15. Kurotobi S, Kawakami N, Shimizu K, et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 2005;26:425-30.
16. Sun YP, Wang WD, Zheng XC, et al. [Levels of serum brain natriuretic peptide and the correlation to heart function in children with Kawasaki disease]. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:169-71.
17. Shiraishi M, Fuse S, Mori T, et al. N-terminal pro-brain natriuretic peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 2013;77:2097-101.
18. Leeflang MM, Deeks JJ, Gatsonis C, et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008;149:889-97.
19. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
20. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
21. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Hosmer DWaL, S. Applied logistic regression. New York: John Wiley & Sons, Inc, 2000.
23. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7:889-94.
24. Jaeschke R, Guyatt GH, Sackett DL, et al. Users' guides to the medical literature: III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients? JAMA 1994;271:703-7.
25. Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007;96:487-91.
26. Nakamura Y, Yashiro M, Uehara R, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2004;46:33-8.
27. Zhao LL, Wang YB, Suo L. [Meta-analysis of the risk factors for coronary artery lesion secondary to Kawasaki disease in Chinese children]. Zhonghua Er Ke Za Zhi 2011;49:459-67.
28. Takemura G, Fujiwara H, Takatsu Y, et al. Venticular expression of atrial and brain natriuretic peptides in patients with myocarditis. Int J Cardiol 1995;52:213-22.
29. Nir A, Lindinger A, Rauh M, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8.